1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Be, X. Hong, Y. Androphy, E.J. Chen, J.J. Baleja, J.D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 40 1293 1299 10.1021/bi0019592 11170455 Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP. 2001 10.2210/pdb1eqx/pdb pdb_00001eqx 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 2101.316 PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN 6.3.2.- E6-INTERACTING PEPTIDE 1 nat polymer no no IPESSELTLQELLGEERR IPESSELTLQELLGEERR A polypeptide(L) n n n n n n n n n n n n n n n n n n human Homo sample 9606 Homo sapiens database_2 pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2001-02-28 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession RCSB Y RCSB 2000-04-06 REL REL This structure was determined using standard 2D homonuclear techniques structures with acceptable covalent geometry, structures with the least restraint violations 30 24 2D NOESY 10 mM Na3PO4 6.2 ambient 288 K simulated annealing 24 closest to the average, fewest violations 2 mM E6ap; 10 mM phosphate buffer; 40% TFE, 60% H2O 40% TFE, 60% H2O BRUNGER structure solution X-PLOR 3.81 BRUNGER refinement X-PLOR 3.81 500 Bruker AMX ILE 1 n 1 ILE 1 A PRO 2 n 2 PRO 2 A GLU 3 n 3 GLU 3 A SER 4 n 4 SER 4 A SER 5 n 5 SER 5 A GLU 6 n 6 GLU 6 A LEU 7 n 7 LEU 7 A THR 8 n 8 THR 8 A LEU 9 n 9 LEU 9 A GLN 10 n 10 GLN 10 A GLU 11 n 11 GLU 11 A LEU 12 n 12 LEU 12 A LEU 13 n 13 LEU 13 A GLY 14 n 14 GLY 14 A GLU 15 n 15 GLU 15 A GLU 16 n 16 GLU 16 A ARG 17 n 17 ARG 17 A ARG 18 n 18 ARG 18 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 2 A A OE1 HH21 GLU ARG 16 17 1.60 3 A A OE1 HE GLU ARG 15 18 1.54 4 A A HB2 HB2 GLU LEU 3 7 1.28 5 A A OE2 HH21 GLU ARG 15 18 1.60 7 A A OE1 HH11 GLU ARG 15 18 1.59 7 A A OE2 HH12 GLU ARG 16 17 1.59 8 A A OE2 HH11 GLU ARG 15 18 1.59 9 A A OE1 HH12 GLU ARG 16 17 1.50 9 A A OE2 HH12 GLU ARG 15 18 1.54 10 A A OE1 HE GLU ARG 15 18 1.54 10 A A OE1 HH22 GLU ARG 16 17 1.54 12 A A OE2 HH11 GLU ARG 15 18 1.55 13 A A OE1 HH12 GLU ARG 15 18 1.52 13 A A H3 OE2 ILE GLU 1 3 1.53 13 A A O HG1 SER THR 5 8 1.58 14 A A OE2 HH21 GLU ARG 16 17 1.59 15 A A H2 OE1 ILE GLU 1 3 1.53 16 A A OE2 HH21 GLU ARG 15 18 1.51 17 A A OE1 HH22 GLU ARG 11 18 1.53 17 A A OE1 HH21 GLU ARG 15 18 1.54 17 A A H2 OE2 ILE GLU 1 3 1.56 18 A A OE1 HE GLU ARG 16 17 1.55 18 A A OE2 HH21 GLU ARG 16 17 1.58 19 A A O HG1 SER THR 4 8 1.59 20 A A OE1 HH21 GLU ARG 15 18 1.55 21 A A OE1 HE GLU ARG 15 18 1.53 23 A A HH12 OXT ARG ARG 17 18 1.59 24 A A OE1 HH21 GLU ARG 15 18 1.56 1 A PRO 2 -78.68 44.73 1 A SER 4 69.40 -39.16 1 A LEU 13 -78.51 32.04 1 A ARG 17 -106.88 40.71 2 A LEU 13 -87.03 37.43 3 A GLU 3 -69.91 55.37 3 A SER 4 -168.63 -54.81 3 A LEU 13 -87.94 42.45 3 A ARG 17 -107.03 70.57 4 A SER 4 54.39 -89.82 4 A LEU 13 -84.62 42.71 5 A GLU 3 -72.12 49.74 6 A LEU 13 -85.97 39.30 7 A SER 4 -75.23 39.04 7 A LEU 13 -91.30 46.08 7 A ARG 17 -85.65 48.92 8 A GLU 3 -56.78 92.24 8 A SER 4 -160.30 -52.50 8 A LEU 13 -89.15 41.76 8 A ARG 17 -99.23 57.76 9 A SER 4 -172.25 -52.94 9 A LEU 13 -97.83 48.33 10 A ARG 17 -110.86 59.47 11 A PRO 2 -70.23 44.00 12 A GLU 3 -75.22 49.01 13 A PRO 2 -68.47 51.87 13 A LEU 13 -90.44 41.95 15 A PRO 2 -66.82 53.36 15 A ARG 17 -101.26 52.24 16 A SER 4 -160.85 -42.01 16 A LEU 13 -86.39 40.03 16 A ARG 17 -145.34 28.93 17 A LEU 13 -83.72 45.85 17 A GLU 16 -85.65 41.27 17 A ARG 17 -152.21 -47.35 18 A LEU 13 -87.97 42.14 18 A ARG 17 -108.37 44.17 19 A SER 4 -155.60 -61.31 19 A ARG 17 -78.28 41.91 20 A LEU 13 -86.13 38.44 21 A LEU 13 -96.52 46.37 21 A ARG 17 -142.17 26.90 22 A SER 4 52.58 -86.99 22 A LEU 13 -94.62 42.21 23 A PRO 2 -68.77 54.29 24 A PRO 2 -16.46 76.56 24 A LEU 13 -84.05 41.36 24 A ARG 17 -84.22 44.94 SOLUTION STRUCTURE DETERMINATION AND MUTATIONAL ANALYSIS OF THE PAPILLOMAVIRUS E6-INTERACTING PEPTIDE OF E6AP 1 N N A SER 4 A SER 4 HELX_P A GLU 16 A GLU 16 1 1 13 LIGASE alpha helix, LIGASE UBE3A_HUMAN UNP 1 Q05086 401 418 1EQX 1 18 Q05086 A 1 1 18 1 P 1